Morgan Stanley reiterated its overweight rating on Dalmia Bharat, while Macquarie advised an outperform rating for Axis Bank. Jefferies sustained a hold rating on Kotak Mahindra Bank, and Investec endorsed a buy rating for Aurobindo Pharma.
Rising geopolitics and indigenisation push place India’s defence sector in a structural growth cycle
India’s defence sector is experiencing a new growth phase driven by rising global security concerns, government initiatives prioritising domestic manufacturing, and a strong procurement pipeline.